Drug Therapy of Prostatic Cancer
- 1 January 1991
- journal article
- review article
- Published by Springer Nature in Drugs & Aging
- Vol. 1 (5), 353-363
- https://doi.org/10.2165/00002512-199101050-00003
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Studies on Prostatic Cancer: I. The Effect of Castration, of Estrogen and of Androgen Injection on Serum Phosphatases in Metastatic Carcinoma of the ProstateJournal of Urology, 2002
- FlutamideDrugs & Aging, 1991
- A Controlled Trial of Leuprolide with and without Flutamide in Prostatic CarcinomaNew England Journal of Medicine, 1989
- Prevention of the Transient Adverse Effects of a Gonadotropin-Releasing Hormone Analogue (Buserelin) in Metastatic Prostatic Carcinoma by Administration of an Antiandrogen (Nilutamide)New England Journal of Medicine, 1989
- Phase III studies to compare goserelin (zoladex) with orchiectomy and with diethylstilbestrol in treatment of prostatic carcinomaUrology, 1989
- Leuprolide versus Diethylstilbestrol for Metastatic Prostate CancerNew England Journal of Medicine, 1984
- Review: Prostate cancer epidemiologyThe Prostate, 1984
- New approach in the treatment of prostate cancer: Complete instead of partial withdrawal of androgensThe Prostate, 1983
- Treatment of Advanced Prostatic Cancer with Parenteral Cyproterone Acetate: A Phase III Randomised Trial*British Journal of Urology, 1980
- Isolation and properties of the FSH and LH-releasing hormoneBiochemical and Biophysical Research Communications, 1971